Nicotine modulation of adolescent dopamine receptor signaling and hypothalamic peptide response. - Test2 - elhamkhani - TriplyDB

Nicotine modulation of adolescent dopamine receptor signaling and hypothalamic peptide response.

Nicotine modulation of adolescent dopamine receptor signaling and hypothalamic peptide response.

http://www.wikidata.org/entity/Q37490030

about

Nicotine and the adolescent brain Adolescent Maturation of Dopamine D1 and D2 Receptor Function and Interactions in Rodents Mechanisms and genetic factors underlying co-use of nicotine and alcohol or other drugs of abuse.

P2860

Q28082026-C3EB4542-7CB8-4E7B-9E09-4F98E3E35A6C Q28552647-66820CE4-5A5E-4DBA-AAA7-297E920DACD7 Q33859960-7AD873BF-7579-4F6A-92B9-D2DD1E568212

P2860

Nicotine modulation of adolescent dopamine receptor signaling and hypothalamic peptide response.

http://www.wikidata.org/entity/Q37490030

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 22 October 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Nicotine modulation of adolesc ...... hypothalamic peptide response.

@en

Nicotine modulation of adolesc ...... hypothalamic peptide response.

@nl

type

label

Nicotine modulation of adolesc ...... hypothalamic peptide response.

@en

Nicotine modulation of adolesc ...... hypothalamic peptide response.

@nl

prefLabel

Nicotine modulation of adolesc ...... hypothalamic peptide response.

@en

Nicotine modulation of adolesc ...... hypothalamic peptide response.

@nl

P1433

Q37490030-ED8ACC5A-8579-400B-A34E-4F94CF7476B8

P1476

Q37490030-82F15AAC-A903-440A-9F75-D183763C818C

P2093

Q37490030-1C017093-0F58-4EBB-A6A9-E7A0D71C8A8A

Q37490030-1ED530DA-B4E8-41C7-A56D-AF9CAEA779B9

Q37490030-A3A52879-0DC6-4AF3-B22D-D7C224538885

Q37490030-AF9E9A4A-22C4-47EA-917B-5D9FA726E48C

Q37490030-BD78A0D8-772C-438A-9E8D-11DB904FACAD

P2860

Q37490030-0071A2EA-D39C-46A1-830B-35FAD028CC1F

Q37490030-010B352A-4E1F-4F9B-B188-9077AE03BAB5

Q37490030-0245E701-F8A9-468E-8D17-61B92A5CC378

Q37490030-074236B7-4176-428F-B9F8-58D90B016529

Q37490030-144EF372-0547-4EC3-9323-B5E5C056678D

Q37490030-17653F93-5C5E-440D-90A0-197AFB40DA5F

Q37490030-21C59E24-991B-4908-B28C-EEB77C91CFC1

Q37490030-29CBB5A1-CF48-489F-885E-017AACD5A8D5

Q37490030-2C090988-16F3-4328-8438-D9096804800B

Q37490030-33B06268-C180-4402-B512-8309C4747778

P304

Q37490030-3F96F4F8-36FF-4877-AE53-F6621B8E16CC

P31

Q37490030-C2EFEC24-7DB1-4B69-A8F5-C24385654451

P356

Q37490030-CE82D4A6-03B1-433A-979D-A8CA167DBF3D

P478

Q37490030-F922AA59-71BB-42F5-BF1A-4852875E7413

P577

Q37490030-F73A4066-D906-4185-BF67-1B32B73504FF

P698

Q37490030-B5DC173E-55C5-4CA0-BA39-33D53ACF3D5A

P921

Q37490030-012aac6f-e02a-4961-a388-61ddf1a533c2

Q37490030-FD7C1E9C-971B-4CB7-B919-059B4EA812C8

P932

Q37490030-AD8D8AD0-1C71-433A-82BA-4DFA5DD3D3B4

P356

J.NEUROPHARM.2013.10.012

P1433

Neuropharmacology

P1476

Nicotine modulation of adolesc ...... hypothalamic peptide response.

@en

P2093

Celina Y Mojica

http://www.w3.org/2001/XMLSchema#string

Frances M Leslie

http://www.w3.org/2001/XMLSchema#string

Jasmin M Dao

http://www.w3.org/2001/XMLSchema#string

Menglu Yuan

http://www.w3.org/2001/XMLSchema#string

Sandra E Loughlin

http://www.w3.org/2001/XMLSchema#string

P2860

Nicotine chemistry, metabolism, kinetics and biomarkers

Signaling mechanisms linking neuronal activity to gene expression and plasticity of the nervous system

Antagonism of the effects of (+)-PD 128907 on midbrain dopamine neurones in rat brain slices by a selective D2 receptor antagonist L-741,626.

Pharmacological actions of NGB 2904, a selective dopamine D3 receptor antagonist, in animal models of drug addiction

Localization and function of the D3 dopamine receptor

Decrease of D2 receptor binding but increase in D2-stimulated G-protein activation, dopamine transporter binding and behavioural sensitization in brains of mice treated with a chronic escalating dose 'binge' cocaine administration paradigm

The adolescent brain and age-related behavioral manifestations

Developmental changes in dopamine neurotransmission in adolescence: behavioral implications and issues in assessment.

A ventral tegmental CRF-glutamate-dopamine interaction in addiction.

Molecular mechanism for a gateway drug: epigenetic changes initiated by nicotine prime gene expression by cocaine.

P304

285-293

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.NEUROPHARM.2013.10.012

http://www.w3.org/2001/XMLSchema#string

P478

77

http://www.w3.org/2001/XMLSchema#string

P577

2013-10-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24157491

http://www.w3.org/2001/XMLSchema#string

P921

P932

3894780

http://www.w3.org/2001/XMLSchema#string